Brevets sur les 10 dernières années

  1. Routier, S. ; Plé, K. ; Gay, M. ; Ben Jamaa, A. ; Chesné, C. ; Li, R. ; Martin, S. ; Daligaux, P.
    Cholic acid Fluorescent probes for in vivo/vitro identification and quantification of hepatic transporters
  2. Patent N° Kind Date Application N° Date
    US20220308043 A1 29 sep. 2022 US2022-17696315 16 mars 2022

        Priority Application :
                      US2021-63161595 16 mars 2021
        ref. chem. Abstract : 2022:2497259

  3. Parissi, V. ; Sousa, S. ; Lapaillerie, D. ; Delelis, O. ; Meertens, L. ; Gallois-Montbrun S. ; Routier, S.
    Pharmaceutical composition, its use as a drug and new compounds, especially for treating SARS-CoV-2 infection
  4. Patent N° Kind Date Application N° Date
    EP4176875 A1 10 may 2023 EP2021-306547 04 nov. 2021
    WO2023079033 A1 11 may 2023 WO2022-EP80737 03 nov. 2022

        Priority Application :
                      EP2021-306547 04 nov. 2021
                      EP2022-305727 17 may 2022
        ref. chem. Abstract : 182:435676

  5. Routier, S. ; Buron, F. ; Suzenet, F. ; Rodrigues, N. ; Chalon, S. ; Vercouillie, J. ; Guilloteau, D. ; Emond, P. ; Marzag, H.
    Radiolabelled compounds for diagnosing cholinergic neurodegenerative diseases
  6. Patent N° Kind Date Application N° Date
    WO2022106714 A1 27 may 2022 WO2021-EP82619 23 nov. 2021
    FR3116433 A1 27 may 2022 FR2020-12024 23 nov. 2020
    CA3198747 A1 27 may 2022 CA2021-3198747 23 nov. 2021
    EP4247437 A1 27 sep. 2023 EP2021-811091 23 nov. 2021

        Priority Application :
                      FR2020-12024 23 nov. 2020
                      WO2021-EP82619 23 nov. 2021
        ref. chem. Abstract : 2022:1369798

  7. Routier, S. ; Bénédetti, H. ; Vallée-Meheust, B. ; Bonnet, P. ; Plé, K. ; Aci-Sèche, S. ; Ruchaud, S. ; Braka, A. ; Champiré, A. ; Andrès, C. ; Vourc’h, P.
    Preparation of 4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-3,6-dihydropyridine--(2H)-carboxamide derivatives as LIMK and ROCK kinases inhibitors for use in the treatment of cancer
  8. Patent N° Kind Date Application N° Date
    EP3915990 A1 01 Dec. 2021 EP2020-305546 26 May 2020
    WO2021239727 A1 02 Dec. 2021 WO2021-EP63890 25 May 2021
    EP4157844 A1 05 mar. 2023 EP2021-728071 25 may 2021
    JP2023527055 T 26 jun. 2023 JP2022-572771 25 may 2021
    US20230312576 A1 05 oct. 2023 US2022-17999749 23 nov. 2022

        Priority Application:
                      EP2020-305546 26 may 2020
                      WO2021-EP63890 25 may 2021
        ref. chem. Abstract : 2021:2607954

  9. Routier, S. ; Buron, F. ; Rodrigues, N. ; Fourrière-Grandclaude, G. ; Vandier, C. ; Chantome, A. ; Potier-Cartereaux, M. ; Gueguinou, M. ; Marionneau-Lambot, S.
    Ion channel inhibitor compounds for cancer treatment
  10. Patent N° Kind Date Application N° Date
    WO 2018215557 A1 29 Nov. 2018 WO 2018-EP63543 23 May 2018
    FR 3066761 A1 30 Nov. 2018 FR 2017-54564 23 May 2017
    FR 3066761 B1 30 Oct. 2020
    EP 3630759 A1 8 Apr. 2020 EP 2018-726802 23 May 2018
    CA 3064484 A1 29 Nov. 2018 CA 2018-3064484 23 May 2018
    JP 2020520982 T 16 Jul. 2020 JP 2019-565186 23 May 2018
    JP7328902 B2 17 Aug. 2023 JP2019-565186 23 may 2018
    US 20210009581 A1 14 Jan. 2021 US 2020-16615947 26 Feb. 2020

        Priority Application
                      FR 2017-54564 A 23 May 2017
                      WO 2018-EP63543 W 23 May 2018
        ref. chem. Abstract : 2018:2337629

  11. Svetlana, V. E. ; Suzenet, F. ; Routier, S. ; Ben Othman, R. ; Collet, A. ; Ivana, M. ; Delatouche, R. ; Petoud, S.
    Lanthanide complexes comprising derivatives of triethylenetetramine-​N,​N,​N',​N'',​N''',​N'''-​hexaacetic acid
  12. Patent N° Kind Date Application N° Date
    WO 2018130545 A1 19 Jul. 2018 WO 2018-EP50517 10 Jan. 2018
    FR 3061713 A1 13 Jul. 2018 FR 2017-50240 11 Jan. 2017
    FR 3061713 B1 14 Feb. 2020
    EP 3568402 A1 20 Nov. 2019 EP 2018-700279 10 Jan. 2018
    EP3568402 B1 02 nov. 2022 EP2018-700279 10 jan. 2018
    US 20190330242 A1 31 Oct. 2019 US 2019-16477080 10 Jul. 2019
    US 10669288 B2 2 Jun. 2020

        Priority Application
                      FR 2017-50240 A 11 Jan. 2017
                      WO 2018-EP50517 W 10 Jan. 2018
        ref. chem. Abstract : 2018:1336212

  13. Routier, S. ; Suzenet, F. ; Chalon, S. ; Buron, F. ; Vercouillie, J. ; Melki, R. ; Boiaryna, L. ; Guilloteau, D. ; Pieri, L.
    Compounds for using in imagery and particularly for the diagnosis of neuro​degenerative diseases
  14. Patent N° Kind Date Application N° Date
    WO 2018055316 A1 29 mar. 2018 WO 2017-FR52592 26 sep. 2017
    FR 3056592 A1 30 mar. 2018 FR 2016-59033 26 sep. 2016
    FR 3056592 B1 16 nov. 2018
    EP 3515912 A1 31 Jul. 2019 EP 2017-783941 26 Sep. 2017
    EP 3515912 B1 14 Oct. 2020
    US 20190211011 A1 11 Jul. 2019 US 2019-1633630925 Mar. 2019
    US 10906900 B2 02 Feb. 2021 US 2019-16336309 25 Mar. 2019

        Priority :
                      FR 2016-59033 A 26 sep. 2016
                      FR 2017-52001 A 10 mar. 2017
                      WO 2017-FR52592 W 26 Sep. 2017
        ref. chem. Abstract : 168:387407

  15. Routier, S. ; Bénédetti, H. ; Buron, F. ; Hiebel, M.-A. ; Saurat, T. ; Guillaumet, G.
    Preparation of trisubstituted pyrido[2,​3-​d]​pyrimidines as inhibitors of PI3K and mTOR kinases
  16. Patent N° Kind Date Application N° Date
    FR 2994572 A1 21 Feb 2014 FR 2012-57856 17 Aug 2012
    FR 2994572 B1 17 Apr 2015
    CA 2881110 A1 20 Feb 2014 CA 2013-2881110 16 Aug 2013
    WO 2014027081 A1 20 Feb 2014 WO 2013-EP67129 16 Aug 2013
    AU 2013304046 A1 26 Feb 2015 AU 2013-304046 16 Aug 2013
    KR 2015046155 A 29 Apr 2015 KR 2015-7006805 16 Aug 2013
    CN 104718203 A 17Jun 2015 CN 2013-80049835 16 Aug 2013
    EP 2885297 A1 24 Jun 2015 EP 2013-750072 16 Aug 2013
    EP 2885297 B1 11 oct. 2017
    BR 112015003033 A2 8 Aug. 2017 BR 2015-112015003033 16 Aug 2013
    ES 2655284 T3 19 Feb. 2018 ES 2013-750072 16 Aug. 2013
    US 20150203489 A1 23 Jul 2015 US 2015-14421402 12 Feb 2015
    US 10202372 B2 12 Feb. 2019
    AU 2017272233 A1 4 Jan. 2018 AU 2017-272233 6 Dec.2017

        Priority application :
                      FR 2012-57856 A 17 Aug. 2012
                      WO 2013-EP67129 W 16 Aug. 2013
                      AU 2013-304046 A3 16 Aug. 2013
        ref. chem. Abstract : 160:370183